Navigation Links
Concentric Medical to Sponsor Randomized Trial

MOUNTAIN VIEW, Calif., Sept. 23 /PRNewswire/ -- Concentric Medical, Inc., the global leader in devices for clot removal in ischemic stroke patients, today announced its plan to sponsor a prospective randomized clinical trial comparing intervention using the Merci Retrieval System(TM) with best medical therapy.

A steering committee comprised of clinical experts from around the world has agreed to support and help guide the trial, named RETRIEVE (Randomized trial of Endovascular TReatment of acute Ischemic strokE Versus mEdical management). The trial, which will enroll in centers throughout the world, will randomize patients between treatment with the Merci Retriever(R) and non-interventional, best medical therapy. Enrollment is expected to begin in 2009.

"We believe a positive randomized trial will significantly improve patient access to interventional technologies, augment the body of evidence, and support a collaborative and comprehensive approach by all clinicians involved in the stroke care chain. Despite a large body of clinical data and over 9,000 patients treated with the Merci Retriever thus far, mechanical intervention is still only used in a very small percentage of stroke cases today," said Maria Sainz, CEO of Concentric Medical.

The Merci Retriever is made with a flexible, shaped Nitinol wire that allows delivery of the Retriever in linear form using standard catheterization techniques. A neurointerventionalist makes a small puncture in the groin to introduce the Merci Retriever into an artery leading to the brain. The Merci Retriever returns to its original shape when deployed in and around the blood clot in the brain.

About Concentric Medical

Concentric Medical is located in Mountain View, California, and was founded in August 1999. The company manufactures and markets the Merci Retrieval System, which is a minimally invasive device that is delivered by a neurointerventionalist into the brain to restore blood flow by engaging, capturing and removing blood clots that cause ischemic stroke. The Merci Retrieval System is available in over 250 leading stroke centers around the world, and has been the subject of two successful clinical trials, MERCI and Multi MERCI. Concentric Medical estimates that over 9,000 patients have been treated with its devices. For more information about Concentric Medical, please visit

Media Contact: Andrew Gordon

1 650-810-1701

SOURCE Concentric Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
2. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
3. 7 Health Ventures Invests in Tulip Medical
4. NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
5. China Sky One Medical, Inc. Announces 26 New Drugs in Clinical Trials
6. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
7. Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology
8. Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit
9. First Ever Study on Alzheimers Disease Treatment in Hispanics Presented at Major Medical Meeting
10. Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
11. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)... , Nov. 25, 2015 ... addition of the "Global Brain Monitoring ... offering. --> ) has ... Brain Monitoring Devices Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... 27, 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces ... This is one of Joplin's most famous and beautiful concert posters. The concert was ... in Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's ...
(Date:11/26/2015)... MI (PRWEB) , ... November 26, 2015 , ... ... for substance abuse located in central Michigan, have come together on Thanksgiving Day ... specially produced video, available for viewing on the Serenity Point YouTube channel, patients ...
(Date:11/26/2015)... Toronto, ON and Cambridge, ON (PRWEB) , ... ... ... announced today the availability of a real-time eReferral system for diagnostic imaging in ... CTs, ultrasounds, X-rays, mammography, BMD and Nuclear Medicine tests directly from their electronic ...
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... San Antonio, TX (PRWEB) , ... November 26, 2015 , ... ... accomplishment! On November 19, 2015, our surgeons performed their 6,000th free flap breast ... Ledoux , “We wake up every day excited to rebuild lives and it’s an ...
Breaking Medicine News(10 mins):